Vericel Corp. (VCEL)
57.42
-2.03
(-3.41%)
USD |
NASDAQ |
Nov 12, 16:00
57.40
-0.02
(-0.03%)
After-Hours: 20:00
Vericel Price : 57.42 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 59.50 | 59.50 | 56.92 | 57.42 | 826630.0 |
| Nov 11, 2026 | 58.42 | 59.75 | 57.76 | 59.45 | 809564.0 |
| Nov 10, 2026 | 58.39 | 59.72 | 57.81 | 59.03 | 1.331M |
| Nov 09, 2026 | 56.00 | 59.48 | 55.60 | 58.39 | 1.751M |
| Nov 06, 2026 | 51.79 | 54.64 | 50.76 | 54.62 | 1.617M |
| Nov 05, 2026 | 50.54 | 55.60 | 49.00 | 51.78 | 2.682M |
| Nov 04, 2026 | 42.07 | 45.98 | 42.07 | 45.48 | 1.808M |
| Nov 03, 2026 | 40.52 | 41.50 | 40.28 | 41.09 | 635185.0 |
| Nov 02, 2026 | 40.29 | 40.88 | 39.44 | 40.51 | 684368.0 |
| Oct 30, 2026 | 43.02 | 43.02 | 40.01 | 40.26 | 598736.0 |
| Oct 29, 2026 | 41.99 | 43.05 | 41.48 | 42.91 | 544832.0 |
| Oct 28, 2026 | 43.05 | 43.50 | 40.59 | 41.09 | 680186.0 |
| Oct 27, 2026 | 43.04 | 43.74 | 42.65 | 43.27 | 558367.0 |
| Oct 26, 2026 | 42.73 | 43.83 | 42.30 | 43.04 | 634753.0 |
| Oct 23, 2026 | 42.99 | 43.00 | 41.75 | 42.53 | 494731.0 |
| Oct 22, 2026 | 41.21 | 43.01 | 40.02 | 42.97 | 604939.0 |
| Oct 21, 2026 | 40.00 | 41.04 | 40.00 | 40.94 | 431999.0 |
| Oct 20, 2026 | 40.81 | 41.02 | 39.97 | 40.58 | 475255.0 |
| Oct 19, 2026 | 40.36 | 40.94 | 40.04 | 40.37 | 334245.0 |
| Oct 16, 2026 | 41.07 | 41.55 | 39.71 | 40.13 | 737148.0 |
| Oct 15, 2026 | 40.77 | 41.60 | 40.26 | 41.02 | 601208.0 |
| Oct 14, 2026 | 39.90 | 40.31 | 39.60 | 40.25 | 384553.0 |
| Oct 13, 2026 | 40.62 | 40.77 | 39.99 | 40.30 | 511740.0 |
| Oct 12, 2026 | 40.30 | 40.81 | 39.00 | 40.62 | 432877.0 |
| Oct 09, 2026 | 39.83 | 41.13 | 39.78 | 40.10 | 506885.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 18.14 |
| Alnylam Pharmaceuticals, Inc. | 156.65 |
| Anika Therapeutics, Inc. | 13.81 |
| Savara, Inc. | 4.72 |
| Biogen, Inc. | 250.48 |
Price Related Metrics
| PE Ratio | 90.87 |
| PS Ratio | 9.216 |
| PEG Ratio | 0.5595 |
| Price to Book Value | 7.629 |
| Price to Free Cash Flow | 51.60 |
| Earnings Yield | 1.10% |
| Market Cap | 2.931B |
| PEGY Ratio | 0.5595 |
| Operating PE Ratio | 110.77 |
| Normalized PE Ratio | 90.88 |